BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 9109104)

  • 1. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
    Gartside SE; Clifford EM; Cowen PJ; Sharp T
    Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test.
    Bourin M; Redrobe JP; Baker GB
    Psychopharmacology (Berl); 1998 Apr; 136(3):226-34. PubMed ID: 9566807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine.
    Hjorth S
    Eur J Pharmacol; 1996 May; 303(3):183-6. PubMed ID: 8813565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
    Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
    Kinney GG; Taber MT; Gribkoff VK
    Mol Neurobiol; 2000 Jun; 21(3):137-52. PubMed ID: 11379796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.
    Romero L; Bel N; Artigas F; de Montigny C; Blier P
    Neuropsychopharmacology; 1996 Oct; 15(4):349-60. PubMed ID: 8887989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does pindolol improve antidepressant action?
    Artigas F; Celada P; Laruelle M; Adell A
    Trends Pharmacol Sci; 2001 May; 22(5):224-8. PubMed ID: 11339972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
    Haddjeri N; Blier P
    J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
    Artigas F
    Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical effects of antidepressant augmentation.
    Howland RH
    Arch Gen Psychiatry; 1995 Feb; 52(2):156. PubMed ID: 7848052
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations].
    Tsuji K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Jun; 22(3):85-95. PubMed ID: 12166089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
    McAllister-Williams RH; Massey AE
    Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.